A dementia-focused transatlantic venture capital initiative has secured $269 million in commitments for its second fund. | A ...

The first blood test to help diagnose Alzheimer’s disease will be available from late June in the US following regulatory ...

Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental The U.S. Food and Drug Administration (FDA) has green-lit a blood test that can help doctors diagnose Alzheimer’s disease ...

Eisai has put direct-to-consumer (DTC) advertising at the heart of its ongoing efforts to expand demand for Leqembi. | Eisai ...

Analysts at BMO Capital Markets said in a weekend note that a non-invasive blood test could help boost uptake of Alzheimer’s ...

Hi, it’s Amber in Hong Kong. Across the strait in Taiwan, breakthrough Alzheimer’s drugs are finally becoming available but ...

U.S. health officials have endorsed the first blood test that can help diagnose Alzheimer’s. The test would help identify ...

The findings show that memory clinics can have “the infrastructure and expertise to safely administer and care for patients ...

Uptake of lecanemab (Leqembi), a monoclonal antibody approved to treat early Alzheimer's disease, appeared to be marked by ...

PHILHEALTH executives, led by its acting president and CEO, Dr. Edwin Mercado, speaks with officials and staff of St. Paul’s Hospital Iloilo on Tuesday, April 29, 2025. Mercado encouraged the ...

MANILA—Malacañang has ordered the dismissal of National Commission of Senior Citizens (NCSC) Commissioner Reymar Mansilungan for serious dishonesty, grave misconduct and conduct prejudicial to ...

MS Franchise Revenue Decline: 11% year-over-year, primarily due to competition. LEQEMBI Sales: $96 million, up approximately 11% sequentially. SKYCLARYS Revenue: $124 million, up 59% year-over ...